Igyxos Biotherapeutics Announces Positive Results from Phase 1 Trial of IGX12, its First-in-Class Monoclonal Antibody for the Treatment of Male and Female Infertility
December 10, 2025 04:00 ET | Source: Igyxos TOURS, France, Dec. 10,…
Lumina Datamatics Earns Great Place To Work Certification for the 3rd Successive Year
MUMBAI, India, Dec. 10, 2025 /PRNewswire/ -- Lumina Datamatics, a strategic partner…
Loyalty Juggernaut Ushers in a New Era of Modern Loyalty Tech: Recognized as a Strong Performer in The Forrester Wave for Loyalty Platforms, Q4 2025
Elevating loyalty to ignite measurable growth through AI-powered decisioning, smarter engagement, and ecosystem…
Miltenyi Biotec Receives ‘Special Recognition Award’ for Pioneering Work in Cell & Gene Therapy at BioSpectrum India Excellence Awards 2025
NEW DELHI, Dec. 9, 2025 /PRNewswire/ -- Miltenyi Biotec has been honoured…
Teleflex Announces Sale of Acute Care, Interventional Urology, and OEM Businesses for $2.03 Billion
WAYNE, Pa., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a…
Alpha Tau Successfully Treats First Patient in its U.S. Trial for Patients with Recurrent Glioblastoma at the James Cancer Hospital at The Ohio State University
- First patient in the world treated with Alpha DaRT® in the…
Manulife Financial Asia Limited Wins ACES Award 2025 for Top Sustainability Advocates in Asia
HONG KONG, Dec. 9, 2025 /PRNewswire/ -- Manulife Financial Asia Limited has…
TransAlta Signs Long-Term Agreement for 700 MW at Centralia Facility Enabling Coal to Natural Gas Conversion
December 09, 2025 07:00 ET | Source: TransAlta Corporation CALGARY, Alberta, Dec.…
Aeluma Files New Patent That Enhances Intellectual Property for Large-Scale High Performance Semiconductor Manufacturing
Strengthens Aeluma’s Heterogeneous Integration Platform and Expands Intellectual Property Portfolio to 35…
Boost Battle: Building Trading Momentum For A Chance at 10,000 USDT in Prizes Weekly
DUBAI, UAE, Dec. 9, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency…
